The American company that makes Tylenol says the FDA should not make proposed changes to the product’s safety label to reflect a possible connection to autism.

In today’s Pharmaceutical Executive Daily, we cover major leadership changes at Novo Nordisk, Kenvue’s request for the FDA to ...

A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer, ...

Perimenopausal women who used estrogen for at least 10 years before their periods stopped had 60% lower odds for breast ...

The FDA defied the advice of its own drug safety experts to warn pregnant women about Tylenol for nearly a decade, internal documents reveal.

A traffic stop for a counterfeit license plate at a Florida I-95 rest area on October 2, 2025, rapidly escalated into a major ...

Kenvue, the maker of Tylenol, is urging U.S. health regulators not to add an autism warning label to it and other ...

“For over a decade — and as recently as August — FDA has fully evaluated the emerging scientific evidence and repeatedly ...

Despite the potential impact of acetaminophen's effect on people's risk perception, the drug nonetheless remains one of the ...

Kenvue, the maker of Tylenol, opposes proposed changes to the product's safety label regarding potential links to autism and ...